Nilogen Oncosystems Announces Opening of Clinical Trial Using Ex Vivo Tumoroids to Predict Immunotherapy Response in Non-Small Cell Lung Cancer (TUMORIN)

/PRNewswire/ -- Nilogen Oncosystems today announced that its clinical observational study TUMORIN (NCT05332925) has commenced enrolment. Patients with...

Related Keywords

Nilogen Oncsystems ,Nilogen Oncosystems , ,Cell Therapies ,Oncolytic Virus ,Soner Altiok ,Chief Scientific Officer ,